Agiliti Inc
NYSE:AGTI
Agiliti Inc
Cash Equivalents
Agiliti Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Agiliti Inc
NYSE:AGTI
|
Cash Equivalents
$20m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Cash Equivalents
$380.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-9%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash Equivalents
$474m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
0%
|
CAGR 10-Years
13%
|
|
CVS Health Corp
NYSE:CVS
|
Cash Equivalents
$8.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
Cigna Corp
NYSE:CI
|
Cash Equivalents
$7.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash Equivalents
$536.8m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
See Also
What is Agiliti Inc's Cash Equivalents?
Cash Equivalents
20m
USD
Based on the financial report for Dec 31, 2023, Agiliti Inc's Cash Equivalents amounts to 20m USD.
What is Agiliti Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
-54%
Over the last year, the Cash Equivalents growth was 258%. The average annual Cash Equivalents growth rates for Agiliti Inc have been -54% over the past three years .